Automated screening of common eye disorders helped by novel deep learning model

Article

A new deep learning model that can identify disease-related features from images of eyes has been unveiled by a group of investigators from Tohoku University.

AI for the eye. The developed lightweight model precisely and rapidly detects image abnormalities related to diseases of the eye. The model is expected to provide accurate analysis on mobile devices/low CPU-GPU resource single board computers used in standalone self-monitoring devices. (Image courtesy of Dr Parmanand Sharma)

AI for the eye. The developed lightweight model precisely and rapidly detects image abnormalities related to diseases of the eye. The model is expected to provide accurate analysis on mobile devices/low CPU-GPU resource single board computers used in standalone self-monitoring devices. (Image courtesy of Dr Parmanand Sharma)

A new deep learning (DL) model that can identify disease-related features from images of eyes has been unveiled by a group of investigators from Tohoku University in Sendai, Japan.

According to the university, this 'lightweight' DL model can be trained with a small number of images, even ones with a high-degree of noise, and is resource-efficient, meaning it is deployable on mobile devices.

Details were published in the journal Scientific Reports.1

With many societies aging and limited medical personnel, DL model reliant self-monitory and tele-screening of diseases are becoming more routine. Yet, deep learning algorithms are generally task specific, and identify or detect general objects such as humans, animals, or road signs.

Identifying diseases, on the other hand, demands precise measurement of tumours, tissue volume, or other sorts of abnormalities. To do so requires a model to look at separate images and mark boundaries in a process known as segmentation. But accurate prediction takes greater computational output, rendering them difficult to deploy on mobile devices.

"There is always a trade-off between accuracy, speed and computational resources when it comes to DL models," noted Dr Toru Nakazawa, co-author of the study and professor at Tohoku University's Department of Ophthalmology. "Our developed model has better segmentation accuracy and enhanced model training reproducibility, even with fewer parameters - making it efficient and more lightweight when compared to other commercial software."

Dr Nakazawa, Dr Parmanand Sharma, Dr Takahiro Ninomiya and students from the Department of Ophthalmology worked with professor Dr Takayuki Okatani from Tohoku University's Graduate School of Information Sciences to produce the model.

According to the university, using low resource devices, the investigators obtained measurements of the foveal avascular zone, a region with the fovea centralis at the centre of the retina, to enhance screening for glaucoma.

"Our model is also capable of detecting/segmenting optic discs and haemorrhages in fundus images with high precision," Dr Nakazawa explained.

In the future, the group is hopeful of deploying the lightweight model to screen for other common eye disorders and other diseases.

Reference
1. Sharma, P., Ninomiya, T., Omodaka, K. et al. A lightweight deep learning model for automatic segmentation and analysis of ophthalmic images. Sci Rep 12, 8508 (2022). https://doi.org/10.1038/s41598-022-12486-w

Newsletter

Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.

Recent Videos
Christine Curcio, PhD, of the University of Alabama at Birmingham Heersink School of Medicine, shares histology update and revised nomenclature for OCT with Sheryl Stevenson of the Eye Care Network and Ophthalmology Times
SriniVas R. Sadda, MD, FARVO, shares key points from his retina presentation at the International SPECTRALIS Symposium
Robert Sergott, MD, describes fluorescence lifetime imaging ophthalmoscopy (FLIO) and the International SPECTRALIS Symposium – And Beyond (ISS) in Heidelberg, Germany.
Rayaz Malik, MBChB, PhD, a professor of medicine at Weill Cornell Medicine - Qatar, spoke with Ophthalmology Times Europe about his presentation. It's titled "An eye on neurodegenerative diseases: Challenging the dogma" at the International SPECTRALIS Sympsoium. In conversation with Hattie Hayes, Ophthalmology Times Europe
Anat Loewenstein, MD, describes her presentation on remote imaging for age-related macular degeneration and geographic atrophy at the International SPECTRALIS Symposium, in conversation with Hattie Hayes of Ophthalmology Times Europe
Tyson Brunstetter, OD, PhD, a US Navy Aerospace Optometrist at the NASA Johnson Space Center in Houston, Texas, shares key takeaways from his keynote at the International SPECTRALIS Symposium (ISS)
Rayaz Malik, MBChB, PhD, shares his presentation, titled An eye on neurodegenerative diseases: Challenging the dogma, at this year's International SPECTRALIS Symposium
At the Retina World Congress, Siegfried Priglinger, MD, speaks about ensuring the best outcomes for preschool-aged patients
At the 2025 ASCRS meeting, Robert Ang, MD said small aperture IOLs can benefit all patients, especially those with complex corneas or who have undergone previous corneal refractive surgery
Viha Vig, MBChB graduate student at the University of Auckland, New Zealand, discusses her poster presentation on the relationship between mitochondiral disease, Alzheimer disease, and other types of dementia.
© 2025 MJH Life Sciences

All rights reserved.